Environmental phthalate exposure and preterm birth.

IMPORTANCE Preterm birth is a leading cause of neonatal mortality, with a variety of contributing causes and risk factors. Environmental exposures represent a group of understudied, but potentially important, factors. Phthalate diesters are used extensively in a variety of consumer products worldwide. Consequently, exposure in pregnant women is highly prevalent. OBJECTIVE To assess the relationship between phthalate exposure during pregnancy and preterm birth. DESIGN, SETTING, AND PARTICIPANTS This nested case-control study was conducted at Brigham and Women's Hospital, Boston, Massachusetts. Women were recruited for a prospective observational cohort study from 2006-2008. Each provided demographic data, biological samples, and information about birth outcomes. From within this group, we selected 130 cases of preterm birth and 352 randomly assigned control participants, and we analyzed urine samples from up to 3 time points during pregnancy for levels of phthalate metabolites. EXPOSURE Phthalate exposure during pregnancy. MAIN OUTCOMES AND MEASURES We examined associations between average levels of phthalate exposure during pregnancy and preterm birth, defined as fewer than 37 weeks of completed gestation, as well as spontaneous preterm birth, defined as preterm preceded by spontaneous preterm labor or preterm premature rupture of the membranes (n = 57). RESULTS Geometric means of the di-2-ethylhexyl phthalate (DEHP) metabolites mono-(2-ethyl)-hexyl phthalate (MEHP) and mono-(2-ethyl-5-carboxypentyl) phthalate (MECPP), as well as mono-n-butyl phthalate (MBP), were significantly higher in cases compared with control participants. In adjusted models, MEHP, MECPP, and  Σ DEHP metabolites were associated with significantly increased odds of preterm birth. When spontaneous preterm births were examined alone, MEHP, mono-(2-ethyl-5-oxohexyl) phthalate, MECPP,  Σ DEHP, MBP, and mono-(3-carboxypropyl) phthalate metabolite levels were all associated with significantly elevated odds of prematurity. CONCLUSIONS AND RELEVANCE Women exposed to phthalates during pregnancy have significantly increased odds of delivering preterm. Steps should be taken to decrease maternal exposure to phthalates during pregnancy.

[1]  Antonia M. Calafat,et al.  Exposure to Phthalates and Breast Cancer Risk in Northern Mexico , 2009, Environmental health perspectives.

[2]  Paige L. Williams,et al.  Maternal urinary metabolites of Di-(2-Ethylhexyl) phthalate in relation to the timing of labor in a US multicenter pregnancy cohort study. , 2009, American journal of epidemiology.

[3]  B. Saelens,et al.  Unexpected results in a randomized dietary trial to reduce phthalate and bisphenol A exposures , 2013, Journal of Exposure Science and Environmental Epidemiology.

[4]  F. Petraglia,et al.  High plasma concentrations of di-(2-ethylhexyl)-phthalate in women with endometriosis. , 2003, Human reproduction.

[5]  G. Presta,et al.  In utero exposure to di-(2-ethylhexyl)phthalate and duration of human pregnancy. , 2003, Environmental health perspectives.

[6]  J. Angerer,et al.  Phthalate exposure in pregnant women and their children in central Taiwan. , 2011, Chemosphere.

[7]  A. Calafat,et al.  Urinary Phthalate Metabolites in Relation to Preterm Birth in Mexico City , 2009, Environmental health perspectives.

[8]  Jim Larson,et al.  Preventing preterm births: analysis of trends and potential reductions with interventions in 39 countries with very high human development index , 2013, The Lancet.

[9]  Antonia M. Calafat,et al.  Prenatal Phenol and Phthalate Exposures and Birth Outcomes , 2008, Environmental health perspectives.

[10]  T. Woodruff,et al.  Environmental Chemicals in Pregnant Women in the United States: NHANES 2003–2004 , 2011, Environmental health perspectives.

[11]  A. Just,et al.  Prenatal Di(2-ethylhexyl)Phthalate Exposure and Length of Gestation Among an Inner-City Cohort , 2009, Pediatrics.

[12]  A. Calafat,et al.  Quantification of 22 phthalate metabolites in human urine. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[13]  E. Richter,et al.  Phthalate exposure among pregnant women in Jerusalem, Israel: results of a pilot study. , 2009, Environment international.

[14]  John D. Meeker,et al.  Exploration of oxidative stress and inflammatory markers in relation to urinary phthalate metabolites: NHANES 1999-2006. , 2012, Environmental science & technology.

[15]  Robin E. Dodson,et al.  Food Packaging and Bisphenol A and Bis(2-Ethyhexyl) Phthalate Exposure: Findings from a Dietary Intervention , 2011, Environmental health perspectives.

[16]  Frederica P. Perera,et al.  Characterization of Phthalate Exposure among Pregnant Women Assessed by Repeat Air and Urine Samples , 2008, Environmental health perspectives.

[17]  Robin M Whyatt,et al.  Prenatal exposures to phthalates among women in New York City and Krakow, Poland. , 2003, Environmental health perspectives.

[18]  P. Liao,et al.  Associations between urinary phthalate monoesters and thyroid hormones in pregnant women. , 2007, Human reproduction.

[19]  Joy E. Lawn,et al.  Preventing preterm births: analysis of trends and potential reductions with interventions in 39 countries with very high human development index , 2013, The Lancet.

[20]  A. Calafat,et al.  Personal care product use and urinary levels of phthalate metabolites in Mexican women. , 2011, Environment international.

[21]  A. Leviton,et al.  American Journal of Epidemiology Original Contribution Pregnancy Disorders That Lead to Delivery before the 28th Week of Gestation: an Epidemiologic Approach to Classification , 2022 .

[22]  A. Calafat,et al.  An estimate of phthalate exposure among pregnant women living in Trujillo, Peru. , 2010, Chemosphere.

[23]  D. Baird,et al.  Consumer product exposures associated with urinary phthalate levels in pregnant women , 2012, Journal of Exposure Science and Environmental Epidemiology.

[24]  G. Latini,et al.  In utero exposure to phthalates and fetal development. , 2006, Current medicinal chemistry.

[25]  R. Hornung,et al.  Estimation of Average Concentration in the Presence of Nondetectable Values , 1990 .

[26]  Roberto Romero,et al.  Epidemiology and causes of preterm birth , 2008, The Lancet.

[27]  J. Yoshinaga,et al.  Prenatal exposure to phthalate esters and PAHs and birth outcomes. , 2010, Environment international.

[28]  S. Swan,et al.  Lifestyle behaviors associated with exposures to endocrine disruptors. , 2012, Neurotoxicology.